Key result
Cholesterol-lowering agents and intensive care therapies commonly induce myopathies through unclear pathogenic mechanisms.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Two major entities continue to be controversial in the field of clinical myotoxicity: the various myopathies that are induced by the cholesterol-lowering agents and the acute quadriplegic myopathy of intensive care. Both conditions are relatively common, but their pathogenesis is unclear. The problematic issues related to these disorders are presented, with suggested topics for future research.
No takes yet. Share an insight, caveat, or question.
Zohar Argov (2000) studied this question. Cholesterol-lowering agents and intensive care treatments commonly induce myopathies and acute quadriplegic myopathy, though their pathogenesis remains unclear.
Synapse has enriched 10 related papers. Consider them for comparative context: